Australian molecular diagnostics firm Clinical Genomics has acquired U.S.-based cancer screening company Enterix from Quest Diagnostics as well as the Sydney-based subsidiary. Clinical Genomics hopes ...

LYNDHURST, N.J., Sept. 7 (UPI) -- Quest Diagnostics said Thursday it has acquired colon screening test maker Enterix in a roughly $43 million cash deal. The privately held Australia-based company ...

Enterix Inc announced its U.S. launch of !nSure FOBT, a new immunochemical fecal occult blood test, at Digestive Disease Week ("DDW") in Atlanta, Georgia. !nSure is an immunochemical fecal occult ...

Quest Diagnostics' ($DGX) ongoing revamp continued this week with news that an Australian company has snatched up its colorectal cancer screening test business ...

Quest Diagnostics, a provider of diagnostic information services, announced that on September 30, it completed the sale of its Enterix colorectal cancer screening test business to Clinical Genomics ...